Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Ocellaris Pharma, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Numab Therapeutics AG
NuCana plc
NRG Oncology
M.D. Anderson Cancer Center
Kymab Limited
Novartis
Novartis
Pfizer
ADC Therapeutics S.A.
Ikena Oncology
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
Genmab
Nektar Therapeutics
Gossamer Bio Inc.
Duke University
Calithera Biosciences, Inc
MacroGenics
Incyte Corporation
Eli Lilly and Company
Cambridge University Hospitals NHS Foundation Trust
Seagen Inc.
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AbbVie
Mayo Clinic
Celldex Therapeutics
Emory University
Calando Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)